Acumen Pharmaceuticals, Inc. Share Price

Acumen Pharmaceuticals, Inc. Share Price

NASDAQ: ABOS | Micro Cap
$2.46
+$0.09 (4.01%) Last updated on 29 Oct, 2026 | 20:38 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Acumen Pharmaceuticals, Inc. Stock Performance

Open
$2.39
Prev. Close
$2.37
Circuit Range
N/A
Day Range
$2.36 - $2.47
Year Range
$1.52 - $3.60
Volume
6,886
Average Traded
$2.44

Acumen Pharmaceuticals, Inc. Share Price Today

As of 29 October 2026, Acumen Pharmaceuticals, Inc.'s share price is $2.46. The stock opened at $2.39, compared to its previous close of $2.37. During today's trading session, Acumen Pharmaceuticals, Inc.'s share price traded between $2.36 and $2.47, with an average price of $2.42. Over the past 52 weeks, the stock has recorded a high of $3.60 and a low of $1.52. In terms of performance, Acumen Pharmaceuticals, Inc.'s share price has risen by 3.14% over the last six months and is up 13.33% on a year-on-year basis.

Acumen Pharmaceuticals, Inc. Share Price Chart

Line chart of the Acumen Pharmaceuticals, Inc. price trend over the selected period. The price rose overall, ranging from 2.36 to 2.47, ending at 2.46.
$2.36$2.47
L
Show Current Price
H

Acumen Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$149.28M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.44
Revenue (TTM)
$0.00
Return On Equity (TTM)
-300.38%
Profit Margin
N/A
Debt to Equity
0.76
Quarterly Earnings Growth YoY
-0.91%

Acumen Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$25.14-$20.74-$32.72-$25.37
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A17.50%-57.76%22.46%

Acumen Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$42.86-$52.37-$102.33-$121.34
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-22.19%-95.40%-18.58%

About Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.

Acumen Pharmaceuticals, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$2.17
$2.45
+10.11%
Sep 2026
$2.86
$2.23
-26.81%
Aug 2026
$2.13
$3.04
+41.40%
Jul 2026
$2.59
$2.15
-19.17%
Jun 2026
$2.60
$2.66
+1.92%
May 2026
$2.38
$2.61
+9.21%
Apr 2026
$2.46
$2.39
+1.49%
Mar 2026
$3.07
$2.35
-25.59%
Feb 2026
$2.54
$3.17
+21.97%
Jan 2026
$2.09
$2.60
+24.46%
Dec 2025
$1.86
$2.08
+10.61%
Nov 2025
$2.17
$1.89
-13.33%

ABOS Share Price FAQs